| Improving socioeconomic status may reduce the burden of malaria in sub Saharan Africa: A systematic review and meta-analysis A Degarege, K Fennie, D Degarege, S Chennupati, P Madhivanan PloS one 14 (1), e0211205, 2019 | 158 | 2019 |
| Association of financial burden with self-rated and mental health in older adults with cancer SMW Jones, T Nguyen, S Chennupati Journal of aging and health 32 (5-6), 394-400, 2020 | 31 | 2020 |
| Out-of-Pocket Costs for Tyrosine Kinase Inhibitors and Patient Outcomes in EGFR- and ALK-Positive Advanced Non–Small-Cell Lung Cancer BHL Goulart, JM Unger, S Chennupati, CR Fedorenko, SD Ramsey JCO Oncology Practice 17 (2), e130-e139, 2021 | 27 | 2021 |
| Comorbidity is associated with higher risk of financial burden in Medicare beneficiaries with cancer but not heart disease or diabetes SMW Jones, S Chennupati, T Nguyen, C Fedorenko, SD Ramsey Medicine 98 (1), e14004, 2019 | 22 | 2019 |
| Utilization of systemic therapy in patients with cancer near the end of life in the pre-versus postimmune checkpoint inhibitor eras AR Khaki, S Chennupati, C Fedorenko, L Li, Q Sun, P Grivas, SD Ramsey, ... JCO oncology practice 17 (11), e1728-e1737, 2021 | 13 | 2021 |
| Adverse events among chronic myelogenous leukemia patients treated with tyrosine kinase inhibitors: a real-world analysis of health plan enrollees EJ Chow, DR Doody, JJ Wilkes, LK Becker, S Chennupati, PE Morin, ... Leukemia & lymphoma 62 (5), 1203-1210, 2021 | 12 | 2021 |
| Health care cost associated with contemporary chronic myelogenous leukemia therapy compared with that of other hematologic malignancies JJ Wilkes, GH Lyman, DR Doody, S Chennupati, LK Becker, PE Morin, ... JCO Oncology Practice 17 (3), e406-e415, 2021 | 10 | 2021 |
| Access to tyrosine kinase inhibitors and survival in patients with advanced EGFR+ and ALK+ positive non–small-cell lung Cancer treated in the real-world BHL Goulart, S Chennupati, CR Fedorenko, SD Ramsey Clinical Lung Cancer 22 (5), e723-e733, 2021 | 9 | 2021 |
| Clinical characteristics, treatment patterns, and healthcare costs and utilization for hepatocellular carcinoma (HCC) patients treated at a large referral center in Washington … V Shankaran, S Chennupati, H Sanchez, Q Sun, L Li, C Fedorenko, A Aly, ... Journal of Hepatocellular Carcinoma, 1597-1606, 2021 | 8 | 2021 |
| Comparison of treatment, cost, and survival in patients with metastatic colorectal cancer in western Washington, United States, and British Columbia, Canada TA Yezefski, D Le, L Chen, CH Speers, S Chennupati, J Snider, S Gill, ... JCO Oncology Practice 16 (5), e425-e432, 2020 | 7 | 2020 |
| Effect of high patient out-of-pocket (OOP) cost for oral tyrosine kinase inhibitors (TKIs) on survival in EGFR and ALK positive stage IV non-small cell lung cancer (NSCLC). BHL Goulart, JM Unger, S Chennupati, K Egan, CR Fedorenko, ... Journal of Clinical Oncology 37 (27_suppl), 3-3, 2019 | 5 | 2019 |
| Effect of Clinical Trial Participation on Costs to Payers in Metastatic Non–Small-Cell Lung Cancer C Merkhofer, S Chennupati, Q Sun, KD Eaton, RG Martins, SD Ramsey, ... JCO Oncology Practice 17 (8), e1225-e1234, 2021 | 4 | 2021 |
| Receipt of screening mammography by insured women diagnosed with breast cancer and impact on outcomes MB Lawson, CI Lee, DS Hippe, S Chennupati, CR Fedorenko, KE Malone, ... Journal of the National Comprehensive Cancer Network 19 (10), 1156-1164, 2021 | 3 | 2021 |
| Health care costs associated with contemporary chronic myelogenous Leukemia (CML) therapy compared to other hematologic malignancies (HEM) JJ Wilkes, GH Lyman, DR Doody, SR Chennupati, L Becker, PE Morin, ... Blood 134, 4753, 2019 | 2 | 2019 |
| Healthcare utilization and costs in hepatocellular carcinoma (HCC) patients treated at a large referral center in Washington (WA) State. V Shankaran, S Chennupati, H Sanchez, Q Sun, A Aly, H Marcus, BS Seal Journal of Clinical Oncology 39 (15_suppl), e16149-e16149, 2021 | 1 | 2021 |
| Financial Burden Over Time in Older Adults with Cancer, Heart Disease, or Diabetes SM Jones, S Chennupati, T Nguyen, CR Fedorenko Value in Health 21, S145, 2018 | 1 | 2018 |
| Comparison of Outcomes and Utilization of Therapy in Multiple Myeloma Patients in the USA and Alberta, Canada AJ Cowan, SR Chennupati, Y Xu, A Li, DA Garcia, E Libby, C Fedorenko, ... Blood 136, 20-21, 2020 | | 2020 |
| Intensity of End of Life Care for Hematologic Malignancy Patients in Western Washington, United States and Alberta, Canada AR Khaki, Y Xu, SR Chennupati, SD Ramsey, C Fedorenko, V Shankaran, ... Blood 136, 21, 2020 | | 2020 |
| Costs to healthcare payers associated with clinical trial (CT) participation in metastatic non-small cell lung cancer (NSCLC). C Merkhofer, S Chennupati, Q Sun, KD Eaton, RG Martins, SD Ramsey, ... Journal of Clinical Oncology 38 (29_suppl), 3-3, 2020 | | 2020 |
| Cost implications of clinical trial (CT) participation in metastatic non-small cell lung cancer (NSCLC). C Merkhofer, S Chennupati, Q Sun, KD Eaton, RG Martins, SD Ramsey, ... Journal of Clinical Oncology 38 (15_suppl), 7084-7084, 2020 | | 2020 |
